Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCl2 expression

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 5306-5314

  Che, Nan ^a   Li, Xia ^a   Zhang, Lu ^a   Liu, Rui ^a   Chen, Haifeng ^a   Gao, Xiang ^b   Shi, Songtao ^c   Chen, Wanjun ^d   Sun, Lingyun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; CCL2 PROTEIN, MOUSE; MATRIX METALLOPROTEINASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; ALLOTRANSPLANTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; C57BL MOUSE; CELL COMMUNICATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL COMMUNICATION; CHEMOKINE CCL2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; PROTEOLYSIS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84910120728     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400036     Document Type: Article

References (41)

1. Prockop, D. J. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74
2. Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
3. Duffy, M. M., T. Ritter, R. Ceredig, and M. D. Griffin. 2011. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res. Ther. 2: 34
4. Spaggiari, G. M., A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta. 2008. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111: 1327-1333
5. Spaggiari, G. M., H. Abdelrazik, F. Becchetti, and L. Moretta. 2009. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583
6. François, M., R. Romieu-Mourez, M. Li, and J. Galipeau. 2012. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol. Ther. 20: 187-195
7. Corcione, A., F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello, F. Cazzanti, M. Risso, F. Gualandi, G. L. Mancardi, V. Pistoia, and A. Uccelli. 2006. Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372
8. Che, N., X. Li, S. Zhou, R. Liu, D. Shi, L. Lu, and L. Sun. 2012. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell. Immunol. 274: 46-53
9. Augello, A., R. Tasso, S. M. Negrini, A. Amateis, F. Indiveri, R. Cancedda, and G. Pennesi. 2005. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35: 1482-1490
10. Ren, G., X. Zhao, L. Zhang, J. Zhang, A. L'Huillier, W. Ling, A. I. Roberts, A. D. Le, S. Shi, C. Shao, and Y. Shi. 2010. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J. Immunol. 184: 2321-2328
11. Liu, H., K. Lu, P. A. MacAry, K. L. Wong, A. Heng, T. Cao, and D. M. Kemeny. 2012. Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells. J. Cell Sci. 125: 200-208
12. Najar, M., G. Raicevic, H. I. Boufker, H. Fayyad Kazan, C. De Bruyn, N. Meuleman, D. Bron, M. Toungouz, and L. Lagneaux. 2010. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cell. Immunol. 264: 171-179
13. Ge, W., J. Jiang, J. Arp, W. Liu, B. Garcia, and H.Wang. 2010. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 90: 1312-1320
14. Sato, K., K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, T. Nagai, K. Muroi, and K. Ozawa. 2007. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109: 228-234
15. Chabannes, D., M. Hill, E. Merieau, J. Rossignol, R. Brion, J. P. Soulillou, I. Anegon, and M. C. Cuturi. 2007. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110: 3691-3694
16. Selmani, Z., A. Naji, E. Gaiffe, L. Obert, P. Tiberghien, N. Rouas-Freiss, E. D. Carosella, and F. Deschaseaux. 2009. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 87(9Suppl.): S62-S66
17. Schena, F., C. Gambini, A. Gregorio, M. Mosconi, D. Reverberi, M. Gattorno, S. Casazza, A. Uccelli, L. Moretta, A. Martini, and E. Traggiai. 2010. Interferong-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 62: 2776-2786
18. Rafei, M., J. Hsieh, S. Fortier, M. Li, S. Yuan, E. Birman, K. Forner, M. N. Boivin, K. Doody, M. Tremblay, et al. 2008. Mesenchymal stromal cellderived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood 112: 4991-4998
19. Rafei, M., P. M. Campeau, A. Aguilar-Mahecha, M. Buchanan, P. Williams, E. Birman, S. Yuan, Y. K. Young, M. N. Boivin, K. Forner, et al. 2009. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol. 182: 5994-6002
20. Koarada, S., and Y. Tada. 2012. RP105-negative B cells in systemic lupus erythematosus. Clin. Dev. Immunol. 2012: 259186
21. Mitchison, N. A., and L. R. Wedderburn. 2000. B cells in autoimmunity. Proc. Natl. Acad. Sci. USA 97: 8750-8751
22. Sturfelt, G., S. Lenhoff, B. Sallerfors, O. Nived, L. Truedsson, and A. G. Sjöholm. 1996. Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor. Ann. Rheum. Dis. 55: 638-641
23. Sun, L. Y., H. Y. Zhang, X. B. Feng, Y. Y. Hou, L. W. Lu, and L. M. Fan. 2007. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 16: 121-128
24. Li, X., L. Liu, D. Meng, D. Wang, J. Zhang, D. Shi, H. Liu, H. Xu, L. Lu, and L. Sun. 2012. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Stem Cells Dev. 21: 2387-2394
25. Nie, Y., C. Lau, A. Lie, G. Chan, and M. Mok. 2010. Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 19: 850-859
26. Sun, L., K. Akiyama, H. Zhang, T. Yamaza, Y. Hou, S. Zhao, T. Xu, A. Le, and S. Shi. 2009. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27: 1421-1432
27. Zhou, K., H. Zhang, O. Jin, X. Feng, G. Yao, Y. Hou, and L. Sun. 2008. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell. Mol. Immunol. 5: 417-424
28. Liang, J., H. Zhang, B. Hua, H. Wang, L. Lu, S. Shi, Y. Hou, X. Zeng, G. S. Gilkeson, and L. Sun. 2010. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study. Ann. Rheum. Dis. 69: 1423-1429
29. Li, X., D. Wang, J. Liang, H. Zhang, and L. Sun. 2013. Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus. Bone Marrow Transplant. 48: 544-550
30. Le Blanc, K., F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, E. Lanino, B. Sundberg, M. E. Bernardo, M. Remberger, et al; Developmental Committee of the European Group for Blood and Marrow Transplantation. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versushost disease: A phase II study. Lancet 371: 1579-1586
31. Wang, F., L. Wang, Z. Shi, and G. Liang. 2013. Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS ONE 8: e80480
32. Chun, H. Y., J. W. Chung, H. A. Kim, J. M. Yun, J. Y. Jeon, Y. M. Ye, S. H. Kim, H. S. Park, and C. H. Suh. 2007. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J. Clin. Immunol. 27: 461-466
33. Jin, T., K. Almehed, H. Carlsten, and H. Forsblad-d'Elia. 2012. Decreased serum levels of TGF-ß1 are associated with renal damage in female patients with systemic lupus erythematosus. Lupus 21: 310-318
34. Ma, X., N. Che, Z. Gu, J. Huang, D. Wang, J. Liang, Y. Hou, G. Gilkeson, L. Lu, and L. Sun. 2013. Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant. 22: 2279-2290
35. Gu, F., I. Molano, P. Ruiz, L. Sun, and G. S. Gilkeson. 2012. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clin. Immunol. 145: 142-152
36. Asari, S., S. Itakura, K. Ferreri, C. P. Liu, Y. Kuroda, F. Kandeel, and Y. Mullen. 2009. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol. 37: 604-615
37. Traggiai, E., S. Volpi, F. Schena, M. Gattorno, F. Ferlito, L. Moretta, and A. Martini. 2008. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 26: 562-569
38. Deshmane, S. L., S. Kremlev, S. Amini, and B. E. Sawaya. 2009. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interferon Cytokine Res. 29: 313-326
39. Marks, S. D., V. Shah, C. Pilkington, and K. Tullus. 2010. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr. Nephrol. 25: 2283-2288
40. McQuibban, G. A., J. H. Gong, J. P. Wong, J. L. Wallace, I. Clark-Lewis, and C. M. Overall. 2002. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with antiinflammatory properties in vivo. Blood 100: 1160-1167
41. McQuibban, G. A., J. H. Gong, E. M. Tam, C. A. McCulloch, I. Clark-Lewis, and C. M. Overall. 2000. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289: 1202-1206